57 results about "Deferent duct" patented technology

The invention provides a method and system for treating disorders in parts of the body. A particular treatment can include on or more of, or some combination of: ablation, nerve modulation, three-dimensional tissue shaping, drug delivery, mapping stimulating, shrinking and reducing strain on structures by altering the geometry thereof and providing bulk to particularly defined regions. The particular body structures or tissues can include one or more of or some combination of region, including: the bladder, esophagus, vagina, penis, larynx, pharynx, aortic arch, abdominal aorta, thoracic, aorta, large intestine, sinus, auditory canal, uterus, vas deferens, trachea, and all associated sphincters. Types of energy that can be applied include radiofrequency, laser, microwave, infrared waves, ultrasound, or some combination thereof. Types of substances that can be applied include pharmaceutical agents such as analgesics, antibiotics, and anti-inflammatory drugs, bulking agents such as biologically non-reactive particles, cooling fluids, or dessicants such as liquid nitrogen for use in cryo-based treatments.

An occlusion clip for permanently occluding a bodily vessel, such as the vas deferens. The occlusion clip has a first leg, a second leg, joined on their proximal ends by a spring coil. The spring coil provides a biased torsional force to the first leg and the second leg, to force them into a closed position. The first leg and the second leg have on their distal ends a vessel occlusion portion that occludes the targeted vessel when the clip is in a closed position.

The invention provides a method and system for treating disorders in parts of the body. A particular treatment can include on or more of, or some combination of: ablation, nerve modulation, three-dimensional tissue shaping, drug delivery, mapping stimulating, shrinking and reducing strain on structures by altering the geometry thereof and providing bulk to particularly defined regions. The particular body structures or tissues can include one or more of or some combination of region, including: the bladder, esophagus, vagina, penis, larynx, pharynx, aortic arch, abdominal aorta, thoracic, aorta, large intestine, sinus, auditory canal, uterus, vas deferens, trachea, and all associated sphincters. Types of energy that can be applied include radiofrequency, laser, microwave, infrared waves, ultrasound, or some combination thereof. Types of substances that can be applied include pharmaceutical agents such as analgesics, antibiotics, and anti-inflammatory drugs, bulking agents such as biologically non-reactive particles, cooling fluids, or dessicants such as liquid nitrogen for use in cryo-based treatments.

A method is provided for local controlled delivery of a drug to the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of a patient in need of treatment. In one embodiment, the method includes implanting a resorbable drug delivery device within the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of the patient. The drug delivery device may include an elastic device body housing at least one drug reservoir which contains at least one drug. In a preferred embodiment, the method further includes releasing the drug from the device in a controlled manner to, typically directly to, the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens.

The invention relates to the use of a thermal reversible gel, such as a copolymer composition, as a biological filler or implant. The gel has a semi-solid form at body temperature, but upon cooling to a temperature below a threshold level, the gel is liquefied and can be re-shaped, re-sized, manipulated or removed from the body. The gel may be used as a subcutaneous implant, a biological filler, joint or tissue spacer, for wrinkle filling or other cosmetic implants, as a soft-tissue replacement for reconstructive surgery, or as a barrier within the lumen of a biological structure, such as a blood vessel. The implant may be used to provide reversible birth control by providing, for example, a reversible barrier to the cervix or a reversible blockage of the lumen of the vas deferens.

There is provided a method for controlling a flow of fluid in the vas deferens in order to obtain a controlled male contraception. The method comprises gently constricting (i.e., without substantially hampering the blood circulation in the tissue wall) at least one portion of the tissue wall to influence the flow vas deferens, and stimulating the constricted wall portion to cause contraction of the wall portion to further influence the flow in the vas deferens. The method can be used for restricting or stopping the flow in the vas deferens, or for actively moving the fluid in the vas deferens, with a low risk of injuring the organ.

A device for occluding a body lumen, and particularly contraceptive or sterilization device for occluding a reproductive tract or lumen to prevent the passage of reproductive cells through the tract or lumen, generally comprising a tubular member, and a mesh member, transversely disposed on the tubular member lumen. The mesh member is permeable to allow for tissue ingrowth, which produces a tissue impregnated mesh occluding the body lumen. The occluding device of the invention can be used in the fallopian tubes of a female patient, the vas deferens of a male patient, or other body lumen.

An occlusion clip for permanently occluding a bodily vessel, such as the vas deferens. The occlusion clip has a first leg, a second leg, joined on their proximal ends by a spring coil. The spring coil provides a biased torsional force to the first leg and the second leg, to force them into a closed position. The first leg and the second leg have on their distal ends a vessel occlusion portion that occludes the targeted vessel when the clip is in a closed position.

Apparatuses and methods for performing non-invasive vasectomies are provided. In a preferred embodiment, an apparatus according to the present invention comprises a main body defining a recess and an ultrasonic transducer disposed adjacent said recess and adapted to emit ultrasonic energy into said recess. A tissue clamp is removeably disposed in the recess and is adapted to receive parallel sections of a scrotum that include a portion of the vas deferens. The clamp is further adapted to position the vas deferens within an effective distance of the ultrasonic transducer. Also, the apparatus includes means for retaining the parallel sections and the vas deferens within the clamp during a procedure.

A male contraception implant for insertion into the vas deferens of a patient includes a tubular member having an internal bore for receiving a guide wire, a bulbous head portion for anchoring the implant and to facilitate its removal in a contraception reversal procedure, a flexible neck portion attached to the enlarged head portion, and a main body portion having three widened segments for occluding the vas deferens. An implantation tool includes an elastic C-shaped slotted ring for holding an externalized portion of the vas deferens during the delivery of the implant.

The Vas Deferens or Fallopian tubes valve system incorporates a small valve in line with either the Vas Deferens or the Fallopian tube in order to open or close fluid communication therein, and effectively a form of birth control. The valve is installed on either one of the Fallopian tubes or Vas Deferens, and is manually or remotely controlled. The small valve is manually controlled via an arm that can be manually rotated to open or close the valve seated there under. A magnetic version of the small valve incorporates magnets on the arm in order to induce motion of the arm upon focusing a magnetic field upon the valve. A remotely operable valve utilizes a solenoid and radio receiver to remotely operate the small valve.

Methods for the synthesis and use of several variations of styrene maleic acid-based polymers and the hydrogel tissue bridges that can be formed from such polymers. Specifically, a method is disclosed for synthesizing a styrene maleic acid-based polymer that can be dissolved in DMSO and injected into the vasa deferentia of male subjects, creating a hydrogel tissue bridge. This hydrogel tissue bridge can occlude the vas deferens, thus forming an effective male contraceptive. Additionally, this male contraceptive can be reversed by injecting the lumen of the vas deferens with a basic buffer solution to dissolve and remove the hydrogel tissue bridge.

A method is provided for local controlled delivery of a drug to the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of a patient in need of treatment. In one embodiment, the method includes implanting a resorbable drug delivery device within the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of the patient. The drug delivery device may include an elastic device body housing at least one drug reservoir which contains at least one drug. In a preferred embodiment, the method further includes releasing the drug from the device in a controlled manner to, typically directly to, the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens.

Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.

An occlusive device and a method of embolizing or occluding a bodily lumen by injecting or otherwise implanting the occlusive device are described. The device includes a polymer or polymer composition and a carbon-based material or nanomaterial such as graphene. The device may be used for sterilizing a human or animal by implanting the device into the vas deferens, fallopian tubes, or uterus, but may also be used to occlude any other bodily ducts, interstitial space, or organs.

Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.

The invention relates to the use of a thermal reversible gel, such as a copolymer composition, as a biological filler or implant. The gel has a semi-solid form at body temperature, but upon cooling to a temperature below a threshold level, the gel is liquefied and can be re-shaped, re-sized, manipulated or removed from the body. The gel may be used as a subcutaneous implant, a biological filler, joint or tissue spacer, for wrinkle filling or other cosmetic implants, as a soft-tissue replacement for reconstructive surgery, or as a barrier within the lumen of a biological structure, such as a blood vessel. The implant may be used to provide reversible birth control by providing, for example, a reversible barrier to the cervix or a reversible blockage of the lumen of the vas deferens.

Disclosed are compositions for site specific delivery in the body including diseased vasculature (e.g., aneurysmal sacs, arteriovenous malformations, etc.), body lumens such as the vas deferens and fallopian tubes, cavities created in vivo for the purpose of tissue bulking, and the like. Also disclosed are methods employing such compositions as well as kits comprising such compositions.

An apparatus, system or device and methods for applying one or more stimuli to an implantation, occlusive device, or embolization are described. The implantation can include a polymer or polymer composition such as a hydrogel and can be used for sterilizing a subject in need of contraception by occluding the vas deferens, fallopian tube(s), or uterus, but can also be used to occlude, in whole or part, any other body ducts or organs. The one or more stimuli can modify the occlusion so that is removed from the body lumen in situ, there by reversing the contraception or other effects of the occlusion.

Methods for the synthesis and use of several variations of styrene maleic acid-based polymers and the hydrogel tissue bridges that can be formed from such polymers. Specifically, a method is disclosed for synthesizing a styrene maleic acid-based polymer that can be dissolved in DMSO and injected into the vasa deferentia of male subjects, creating a hydrogel tissue bridge. This hydrogel tissue bridge can occlude the vas deferens, thus forming an effective male contraceptive. Additionally, this male contraceptive can be reversed by injecting the lumen of the vas deferens with a basic buffer solution to dissolve and remove the hydrogel tissue bridge.

Methods for the synthesis and use of several variations of styrene maleic acid-based polymers and the hydrogel tissue bridges that can be formed from such polymers. Specifically, a method is disclosed for synthesizing a styrene maleic acid-based polymer that can be dissolved in DMSO and injected into the vasa deferentia of male subjects, creating a hydrogel tissue bridge. This hydrogel tissue bridge can occlude the vas deferens, thus forming an effective male contraceptive. Additionally, this male contraceptive can be reversed by injecting the lumen of the vas deferens with a basic buffer solution to dissolve and remove the hydrogel tissue bridge.

A cannula implantation instrument for use with the delivery of guide wire based implants includes a handle having an open slot for receiving a guide wire and a cavity for receiving an implant pre-mounted on the guide wire, a cannula having an open slot for also receiving a guide wire and a sharpened tip for introducing the cannula and guide wire simultaneously into the vas deferens of a patient, and a guide wire on which an intra vas implant is pre-mounted. The instrument further includes a safety clip on the handle that secures the guide wire and / or implant to the handle until released by a physician. The cannula implantation instrument may be ergonomically formed to provide comfort and ease while being handled by the physician.

Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.

The invention provides an artificial insemination method of breeder cocks. The method comprises the following steps: 1) artificially feeding breeder cocks before semen collection, namely selecting 55-week-old artificial insemination breeder cocks, adding feed additives to the conventional feed according to a ratio of 1.5-2.0wt%, feeding the breeder cocks until the breeder cocks are at the age of 68 weeks or the production cycle is ended according to a feeding procedure of continuously feeding for 7 days and later stopping for 7 days; 2) collecting semens; 3) diluting the semens, namely using semen diluents of which the volume is 2-4 times of that of the semen and slowly adding to semen collecting test tubes along the tube walls of the semen collecting test tubes, and then gently turning the semen collecting test tubes and repeating for 3-4 times; 4) carrying out artificial insemination, namely turning the anus of hens by anus turning members, transferring the diluted semens to deferent ducts by inseminators, and then gently inserting the deferent ducts into fallopian tubes of the hens by the inseminators and conveying the semens in the deferent ducts to conveying pipes, so as to realize the artificial insemination. The artificial insemination method disclosed by the invention is high in semen viability and insemination rate.

The invention relates to a fish gonad determination method. Said method includes the following steps: placing the fish to be examined into an electric anesthetization tank, adopting 25-30 V low-voltage dierct current to apply said direct current to fish the make electric anesthetization, then using an endoscope specially-design for fish and inserting it into genital operature and making dynamic determination from uterine tube / deferent duct to two sides or ovary / testis to obtain determinal data, then utilizing the gonadal development index parameters of different development stages of fish and determined gondal development condition to make male and female identification.

There is provided a method for controlling a flow of fluid in the vas deferens in order to obtain a controlled male contraception. The method comprises gently constricting (i.e., without substantially hampering the blood circulation in the tissue wall) at least one portion of the tissue wall to influence the flow vas deferens, and stimulating the constricted wall portion to cause contraction of the wall portion to further influence the flow in the vas deferens. The method can be used for restricting or stopping the flow in the vas deferens, or for actively moving the fluid in the vas deferens, with a low risk of injuring the organ.

The invention provides a porcine embryo transplantation method, which comprises the steps as follows: (1) a recipient sow is processed through manual restraint, a cunnus part is cleaned, a deep uterus spermaduct outer-tube is inserted into a vagina until a spongy top plugs up a cervical orifice, and then a flexibility tubule is inserted in a deep uterus spermaduct to reach a uterine cornu; (2) the tubule is rinsed by perfusing embryo culture media for the first time, the embryo culture media is perfused for the second time, a porcine embryo which grows to reach a blastula stage is injected into the tubule from an external opening and is mixed with the embryo culture media, the mixed solution is led by the tubule to enter the uterine cornu, then the embryo culture media is injected to rinse the tubule for the third time, the part of the external opening of the tubule is folded, and liquid flows into a uterus completely by utilizing air-pressure; and (3) the deep uterus spermaduct outer-tube is drawn out after the tubule is drawn out, and then the recipient sow is led to keep the standing posture for at least 15 minutes. During the process of porcine embryo transplantation, the porcine embryo transplantation method needs no anaesthesia and operation, and solves the problems that injury and pains are brought to the recipient sow during the process of the porcine embryo transplantation.

Described are restraints, and methods of using and making the restraints, for restraining a man's testicular retraction response to sexual stimulation. It is believed that the restraints and methods of use thereby tend to slow or postpone the onset of the man's climax, with the potential to prolong the pleasure of the man and / or his sexual partner. More particularly, clip restraints and loop restraints are described and illustrated. The clip restraints are configured to grip a portion of the scrotum and to present deflection or obstruction features above the reposed positions of each of the man's testicles, configured to deflect or obstruct the movement of the testicles toward a retracted position associated with the onset of the man's sexual climax. Advantageously, clips according to the invention may fold to a narrow thickness, convenient for carrying in a pocket or wallet. Clip members of the restraints may be attracted by magnets, biased by springs, or manually adjusted to a stable gripping position. The loop restraints comprise left-hand and right-hand loops configured to extend around a portion of the scrotum and to define a restraint opening, confining at least a restrained portion of the respective testicle to one side of the restrained opening to limit retraction of the respective testicle through the opening in a direction toward the respective vas deferens.

An apparatus for irrigating the vas deferens in connection with a vasectomy reversal is described. The apparatus comprises a fluid delivery device having a first portion that connects to the vas deferens, the fluid delivery device connecting such that a catheter tip inserts into the vas deferens and is held in stable position relative thereto and such that fluid enters the vas deferens through the catheter tip.

A medical device is provided which forms a physical barrier between the two ends of a cut vas during a vasectomy procedure, comprising a biodegradable, polymeric cap that is applied over at least one prostatic end of the vas, the cap including a fastener for preventing premature dislodgement.